| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/04/2007 | CA2125643C Pharmaceutical composition having analgesic activity |
| 09/04/2007 | CA2116238C Oral 1 .alpha.-hydroxyprevitamin d |
| 08/30/2007 | WO2007098504A1 Prodrugs of curcumin analogs |
| 08/30/2007 | WO2007098436A2 Platelet stabilization |
| 08/30/2007 | WO2007098418A1 Compounds having 5-ht6 receptor affinity |
| 08/30/2007 | WO2007098408A2 Novel application of topical anesthetics for modulation of neurogenic tremor |
| 08/30/2007 | WO2007098393A2 Compounds and methods for treating diseases with trpv4 channel receptors |
| 08/30/2007 | WO2007098390A2 Method for treating resistant hypertension |
| 08/30/2007 | WO2007098386A1 Pyrazolylquinazolinones as potassium channel openers |
| 08/30/2007 | WO2007098384A2 Tetracyclic steroid derivatives useful as progesterone receptor modulators |
| 08/30/2007 | WO2007098356A1 Congeners of milnacipran as monoamine re-uptake |
| 08/30/2007 | WO2007098352A2 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors |
| 08/30/2007 | WO2007098281A2 Oxysterol compounds and the hedgehog pathway |
| 08/30/2007 | WO2007098273A2 Novel crystalline forms of armodafinil and preparation thereof |
| 08/30/2007 | WO2007098270A2 Co-crystals comprising vx-950 and pharmaceutical compositions comprising the same |
| 08/30/2007 | WO2007098264A2 Use of rasagiline for the treatment of multiple system atrophy |
| 08/30/2007 | WO2007098252A2 Methods and compositions for treating hyperalgesia |
| 08/30/2007 | WO2007098240A2 Compositions to reduce blood glucose levels and treat diabetes |
| 08/30/2007 | WO2007098229A2 Geldanamycin derivatives and method of use thereof |
| 08/30/2007 | WO2007098214A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| 08/30/2007 | WO2007098183A2 Treatment of cancer with 2-deoxygalactose |
| 08/30/2007 | WO2007098142A2 Oxazole ketones as modulators of fatty acid amide hydrolase |
| 08/30/2007 | WO2007098139A2 Anticancer agents |
| 08/30/2007 | WO2007098135A2 Anti-microbial compositions |
| 08/30/2007 | WO2007098128A2 Phenylephrine-containing liquid formulations |
| 08/30/2007 | WO2007098118A2 Antineoplastic and curcumin derivatives and methods of preparation and use |
| 08/30/2007 | WO2007098099A2 Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor |
| 08/30/2007 | WO2007098091A2 Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs |
| 08/30/2007 | WO2007098090A2 Treatment of hyperproliferative diseases with n-oxides of estrogen receptor modulators |
| 08/30/2007 | WO2007098089A2 Treatment of hyperproliferative diseases with methotrexate n-oxide and analogs |
| 08/30/2007 | WO2007098086A2 Hydroxypiperidine derivatives and uses thereof |
| 08/30/2007 | WO2007098047A2 Methods and compositions for the treatment of parkinson's disease |
| 08/30/2007 | WO2007098010A2 Improved low molecular weight myc-max inhibitors |
| 08/30/2007 | WO2007097992A2 Novel heterocyclic diphenyl ethers |
| 08/30/2007 | WO2007097991A2 Methods and kits for dosing of antiviral agents |
| 08/30/2007 | WO2007097989A2 A composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer |
| 08/30/2007 | WO2007097980A2 Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy |
| 08/30/2007 | WO2007097976A1 Process for preparing intermediates to 5-ht4 receptor agonist compounds |
| 08/30/2007 | WO2007097961A1 Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage |
| 08/30/2007 | WO2007097951A2 Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate |
| 08/30/2007 | WO2007097937A1 Pyrrolidine derivatives as erk inhibitors |
| 08/30/2007 | WO2007097931A2 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 08/30/2007 | WO2007097889A2 Fluoroquinolone compositions |
| 08/30/2007 | WO2007097888A2 Fluoroquinolone carboxylic acid salt compositions |
| 08/30/2007 | WO2007097871A2 Piperazine derivatives |
| 08/30/2007 | WO2007097839A2 Ansamycin analogs or heat shock 90 inhibitors in combination with pdt treatin conditions of the eye |
| 08/30/2007 | WO2007097770A1 Metoprolol succinate e.r. tablets and methods for their preparation |
| 08/30/2007 | WO2007097765A1 Methods and compositions for bactericide, bacteriostatic and anti-inflammation |
| 08/30/2007 | WO2007097720A2 Method and reagents for treating hepatic fibrosis and inflammation |
| 08/30/2007 | WO2007097707A1 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives |
| 08/30/2007 | WO2007097697A1 Therapeutic quinoline compounds that are 5ht1b modulators |
| 08/30/2007 | WO2007097648A1 Methods of treating diseases using inhibitors of nucleoside phosphorylases and nucleosidases |
| 08/30/2007 | WO2007097647A1 Methods of treating cancer |
| 08/30/2007 | WO2007097643A1 Analogues of coformycin and their use for treating protozoan parasite infections |
| 08/30/2007 | WO2007097502A1 Composition for reducing the exudation of serum proteins |
| 08/30/2007 | WO2007097470A2 Fused nitrogen- comprising heterocyclic compound |
| 08/30/2007 | WO2007097455A1 Novel compound isolated from plant 'pau-ferro' |
| 08/30/2007 | WO2007097452A1 Medical blister package |
| 08/30/2007 | WO2007097451A1 Pharmaceutical package |
| 08/30/2007 | WO2007097450A1 Compound with antimalarial activity and antimalarial drug containing the same as active ingredient |
| 08/30/2007 | WO2007097412A1 Oil-in-water emulsion composition containing licorice-derived polyphenol |
| 08/30/2007 | WO2007097403A1 Remedy or preventive for digestive ulcer |
| 08/30/2007 | WO2007097386A1 Stabilized pharmaceutical composition |
| 08/30/2007 | WO2007097325A1 Pharmaceutical composition comprising oseltamivir phosphate |
| 08/30/2007 | WO2007097317A1 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative |
| 08/30/2007 | WO2007097301A1 Prophylactic or therapeutic agent for cerebral ischemia or cerebral ischemic reperfusion injury in stroke |
| 08/30/2007 | WO2007097289A1 Novel pharmaceutical |
| 08/30/2007 | WO2007097286A1 Medicine and functional food for controlling or relieving itching and inflammation |
| 08/30/2007 | WO2007097276A1 Pyrrole derivative or salt thereof |
| 08/30/2007 | WO2007097205A1 Eyedrops |
| 08/30/2007 | WO2007097203A1 Feed additive |
| 08/30/2007 | WO2007097197A1 Amide derivative or salt thereof |
| 08/30/2007 | WO2007097010A1 Substance fki-2342 and process for production thereof |
| 08/30/2007 | WO2007096931A2 Use of piperacillin in topical intravaginal preparations for the treatment of vaginal bacterial infections |
| 08/30/2007 | WO2007096902A2 Solid oral dosage forms of griseofulvin |
| 08/30/2007 | WO2007096901A1 Novel dihydrate form of amifostine and process for its preparation |
| 08/30/2007 | WO2007096900A1 Stable pharmaceutical composition of taxanes |
| 08/30/2007 | WO2007096886A2 Composition and methods for treating and preventing age-related macular degeneration |
| 08/30/2007 | WO2007096882A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 08/30/2007 | WO2007096875A2 Novel polymorphs of montelukast ammonium salts and processes for preparation therefor |
| 08/30/2007 | WO2007096751A1 Process for the preparation of atorvastatin calcium |
| 08/30/2007 | WO2007096744A1 Methods for the treatment of macular degeneration and related eye conditions |
| 08/30/2007 | WO2007096743A1 Substituted quinazolines as pde10 inhibitors |
| 08/30/2007 | WO2007096740A2 Novel cephalosporins |
| 08/30/2007 | WO2007096733A2 Desloratadine-containing formulation stabilized with cyclodextrin |
| 08/30/2007 | WO2007096694A1 Combination of neuroactivating active principles |
| 08/30/2007 | WO2007096643A1 Tea |
| 08/30/2007 | WO2007096601A2 Antimicrobial formulations comprising a quinone and a copper salt |
| 08/30/2007 | WO2007096588A1 Salt of cd 80 antagonist |
| 08/30/2007 | WO2007096532A1 Mannosyl-1 phosphates, preparation method and therapeutic use, in particular against the cdg-ia syndrome |
| 08/30/2007 | WO2007096489A1 Novel pharmaceutical compositions for optimizing replacement treatments and broadening the pharmacopeia for the overall treatment of addictions |
| 08/30/2007 | WO2007096471A1 Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors |
| 08/30/2007 | WO2007096395A1 Indolopyridines as eg5 kinesin modulators |
| 08/30/2007 | WO2007096393A1 Indolopyridines as eg5 kinesin modulators |
| 08/30/2007 | WO2007096362A1 Heterocyclic compounds and their use in the treatment of cardiovascular disease |
| 08/30/2007 | WO2007096352A1 5-amino-6-bromo-n-{ [1- (tetrahydr0-2h-pyran-4-ylmethyl) -4-piperidinyl] methyl}-3, 4 -dihydro-2h-chromene-8-carboxamide as 5-ht4 receptor agonist |
| 08/30/2007 | WO2007096351A1 2,4-diaminopyrimidine derivatives for the treatment and/or prevention of cancer, infections, inflammatory and autoimmune disorders |
| 08/30/2007 | WO2007096334A1 Pyrrolopyrrolones active as kinase inhibitors |
| 08/30/2007 | WO2007096315A1 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as plk1 inhibitors |
| 08/30/2007 | WO2007096300A1 Benzimidazolone derivatives for the treatment of urinary incontinence |